Cocaine enhances HIV-1 gp120-induced lymphatic endothelial dysfunction in the lung

Physiological Reports

Volumn 3, Issue 8, 2015, Pages

  Zhang, Xuefeng ^a   Jiang, Susan ^a   Yu, Jinlong ^a,b   Kuzontkoski, Paula M ^a,c   Groopman, Jerome E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c EBSCO Information Services   (United States)

Author keywords

Cocaine; D4 receptor; Fibronectin; HIV; Lymphatic endothelial cells; Sigma 1 receptor

Indexed keywords

C REACTIVE PROTEIN; COCAINE; DOPAMINE 4 RECEPTOR; FIBRONECTIN; GLYCOPROTEIN GP 120; PAXILLIN; RECOMBINANT GLYCOPROTEIN GP 120; ROUNDABOUT RECEPTOR; SIGMA 1 OPIATE RECEPTOR; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL DEATH; CELL SIGNALING ASSAY; CELL STIMULATION; COCAINE DEPENDENCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EXPOSURE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG INJURY; LYMPHATIC SYSTEM; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUNEL ASSAY; WESTERN BLOTTING; WOUND HEALING;

EID: 85006060269     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12482     Document Type: Article

References (79)

1. Afessa, B., W. Green, J. Chiao, and W. Frederick. 1998. Pulmonary complications of HIV infection: autopsy findings. Chest 113:1225–1229.
2. Albuquerque, M. L., C. M. Waters, U. Savla, H. W. Schnaper, and A. S. Flozak. 2000. Shear stress enhances human endothelial cell wound closure in vitro. Am. J. Physiol. Heart Circ. Physiol. 279:H293–302.
3. Alitalo, K. 2011. The lymphatic vasculature in disease. Nat. Med. 17:1371–1380.
4. Almodovar, S., P. Y. Hsue, J. Morelli, L. Huang, S. C. Flores, and Lung, HIV Study. 2011. Pathogenesis of HIV-associated pulmonary hypertension: potential role of HIV-1 Nef. Proc. Am. Thorac. Soc. 8:308–312.
5. Araos, P., M. Pedraz, A. Serrano, M. Lucena, V. Barrios, N. Garcia-Marchena, et al. 2015. Plasma profile of proinflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity. Addict. Biol. 20:756–772.
6. Bailey, M. E., A. E. Fraire, S. D. Greenberg, J. Barnard, and P. T. Cagle. 1994. Pulmonary histopathology in cocaine abusers. Hum. Pathol. 25:203–207.
7. Beaulieu, J. M., and R. R. Gainetdinov. 2011. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63:182–217.
8. Benzaquen, B. S., V. Cohen, and M. J. Eisenberg. 2001. Effects of cocaine on the coronary arteries. Am. Heart J. 142:402–410.
9. Birdsall, H. H., W. J. Porter, D. M. Green, J. Rubio, J. Trial, and R. D. Rossen. 2004. Impact of fibronectin fragments on the transendothelial migration of HIV-infected leukocytes and the development of subendothelial foci of infectious leukocytes. J. Immunol. 173:2746–2754.
10. de Brito, L. C., F. R. Teles, R. P. Teles, P. M. Nogueira, L. Q. Vieira, and A. P. Ribeiro Sobrinho. 2015. Immunological profile of periapical endodontic infections from HIV- and HIV+ patients. Int. Endod. J. 48:533–541.
11. Caldwell, J., and P. S. Sever. 1974. The biochemical pharmacology of abused drugs. I. Amphetamines, cocaine, and LSD. Clin. Pharmacol. Ther. 16:625–638.
12. Chen, Y., Q. Ke, Y. F. Xiao, G. Wu, E. Kaplan, T. G. Hampton, et al. 2005. Cocaine and catecholamines enhance inflammatory cell retention in the coronary circulation of mice by upregulation of adhesion molecules. Am. J. Physiol. Heart Circ. Physiol. 288:H2323–2331.
13. Cone, E. J., D. Yousefnejad, M. J. Hillsgrove, B. Holicky, and W. D. Darwin. 1995. Passive inhalation of cocaine. J. Anal. Toxicol. 19:399–411.
14. Dabbouseh, N. M., and A. Ardelt. 2011. Cocaine mediated apoptosis of vascular cells as a mechanism for carotid artery dissection leading to ischemic stroke. Med. Hypotheses 77:201–203.
15. Dalvi, P., K. Wang, J. Mermis, R. Zeng, M. Sanderson, S. Johnson, et al. 2014. HIV-1/cocaine induced oxidative stress disrupts tight junction protein-1 in human pulmonary microvascular endothelial cells: role of Ras/ERK1/2 pathway. PLoS ONE 9:e85246.
16. De Giorgi, A., F. Fabbian, M. Pala, F. Bonetti, I. Babini, I. Bagnaresi, et al. 2012. Cocaine and acute vascular diseases. Curr. Drug Abuse Rev. 5:129–134.
17. Dhillon, N. K., F. Peng, S. Bokhari, S. Callen, S. H. Shin, X. Zhu, et al. 2008. Cocaine-mediated alteration in tight junction protein expression and modulation of CCL2/CCR2 axis across the blood-brain barrier: implications for HIVdementia. J. Neuroimmune Pharmacol. 3:52–56.
18. Dhillon, N. K., F. Li, B. Xue, O. Tawfik, S. Morgello, S. Buch, et al. 2011. Effect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction. Am. J. Respir. Cell Mol. Biol. 45:40–52.
19. Drent, M., P. Wijnen, and A. Bast. 2012. Interstitial lung damage due to cocaine abuse: pathogenesis, pharmacogenomics and therapy. Curr. Med. Chem. 19:5607–5611.
20. Farber, H. W., and J. Loscalzo. 2004. Pulmonary arterial hypertension. New. Engl. J. Med. 351:1655–1665.
21. Fiala, M., X. H. Gan, L. Zhang, S. D. House, T. Newton, M. C. Graves, et al. 1998. Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine’s connection to AIDS dementia and vasculitis? Adv. Exp. Med. Biol. 437:199–205.
22. Fiala, M., A. J. Eshleman, J. Cashman, J. Lin, A. S. Lossinsky, V. Suarez, et al. 2005. Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells. J. Neurovirol. 11:281–291.
23. Gan, X., L. Zhang, O. Berger, M. F. Stins, D. Way, D. D. Taub, et al. 1999. Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin. Immunol. 91:68–76.
24. Gebhard, C., A. Breitenstein, A. Akhmedov, C. E. Gebhard, G. G. Camici, T. F. Luscher, et al. 2010. Amphetamines induce tissue factor and impair tissue factor pathway inhibitor: role of dopamine receptor type 4. Eur. Heart J. 31:1780–1791.
25. Gingo, M. R., and A. Morris. 2013. Pathogenesis of HIV and the lung. Curr. HIV/AIDS Rep. 10:42–50.
26. Gorbunova, E. E., I. N. Gavrilovskaya, and E. R. Mackow. 2013. Slit2-Robo4 receptor responses inhibit ANDV directed permeability of human lung microvascular endothelial cells. Antiviral Res. 99:108–112.
27. He, J., Y. Xiao, and L. Zhang. 2000. Cocaine induces apoptosis in human coronary artery endothelial cells. J. Cardiovasc. Pharmacol. 35:572–580.
28. Helmeste, D. M., T. Shioiri, M. Mitsuhashi, and S. W. Tang. 1999. Binding of [3H]U-101958 to sigma1 receptor-like sites in human cerebellum and neuroblastoma cells. Eur. J. Pharmacol. 370:205–209.
29. Henderson, W. W., R. Ruhl, P. Lewis, M. Bentley, J. A. Nelson, and A. V. Moses. 2004. Human immunodeficiency virus (HIV) type 1 Vpu induces the expression of CD40 in endothelial cells and regulates HIV-induced adhesion of Blymphoma cells. J. Virol. 78:4408–4420.
30. Hendricks-Munoz, K. D., R. P. Gerrets, R. D. Higgins, J. L. Munoz, and V. V. Caines. 1996. Cocaine-stimulated endothelin-1 release is decreased by angiotensin-converting enzyme inhibitors in cultured endothelial cells. Cardiovasc. Res. 31:117–123.
31. Inaba, T. 1989. Cocaine: pharmacokinetics and biotransformation in man. Can. J. Physiol. Pharmacol. 67:1154–1157.
32. Jakus, Z., J. P. Gleghorn, D. R. Enis, A. Sen, S. Chia, X. Liu, et al. 2014. Lymphatic function is required prenatally for lung inflation at birth. J. Exp. Med. 211:815–826.
33. Jones, C. A., N. R. London, H. Chen, K. W. Park, D. Sauvaget, R. A. Stockton, et al. 2008. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat. Med. 14:448–453.
34. Jones, C. A., N. Nishiya, N. R. London, W. Zhu, L. K. Sorensen, A. C. Chan, et al. 2009. Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity. Nat. Cell Biol. 11:1325–1331.
35. Kanmogne, G. D., C. Primeaux, and P. Grammas. 2005. Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins. Biochem. Biophys. Res. Commun. 333:1107–1115.
36. Kaufman, M. J., C. C. Streeter, T. L. Barros, O. Sarid-Segal, M. Afshar, H. Tian, et al. 2007. Reduced plasma nitric oxide end products in cocaine-dependent men. J. Addict. Med. 1:96–103.
37. Kulkarni, R. M., A. Herman, M. Ikegami, J. M. Greenberg, and A. L. Akeson. 2011. Lymphatic ontogeny and effect of hypoplasia in developing lung. Mech. Dev. 128:29–40.
38. Lancerotto, L., and D. P. Orgill. 2014. Mechanoregulation of angiogenesis in wound healing. Adv. Wound Care 3:626–634.
39. Langa, F., X. Codony, V. Tovar, A. Lavado, E. Gimenez, P. Cozar, et al. 2003. Generation and phenotypic analysis of sigma receptor type I (sigma 1) knockout mice. Eur. J. Neurosci. 18:2188–2196.
40. Lederman, M. M., D. Sereni, G. Simonneau, and N. F. Voelkel. 2008. Pulmonary arterial hypertension and its association with HIV infection: an overview. AIDS 22(Suppl 3):S1–S6.
41. Lee, Y. W., B. Hennig, M. Fiala, K. S. Kim, and M. Toborek. 2001. Cocaine activates redox-regulated transcription factors and induces TNF-alpha expression in human brain endothelial cells. Brain Res. 920:125–133.
42. Lim, R., and M. Lappas. 2014. Slit2 exerts anti-inflammatory actions in human placenta and is decreased with maternal obesity. Am. J. Reprod. Immunol. 73:66–78.
43. London, N. R., W. Zhu, F. A. Bozza, M. C. Smith, D. M. Greif, L. K. Sorensen, et al. 2010. Targeting Robo4- dependent slit signaling to survive the cytokine storm in sepsis and influenza. Sci. Transl. Med. 2:23ra19.
44. Mao, J. T., L. X. Zhu, S. Sharma, K. Chen, M. Huang, S. J. Santiago, et al. 1997. Cocaine inhibits human endothelial cell IL-8 production: the role of transforming growth factorbeta. Cell. Immunol. 181:38–43.
45. Marecki, J. C., C. D. Cool, J. E. Parr, V. E. Beckey, P. A. Luciw, A. F. Tarantal, et al. 2006. HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nefinfected macaques. Am. J. Respir. Crit. Care Med. 174:437–445.
46. McNellis, E. M., S. M. Mabry, E. Taboada, and I. I. Ekekezie. 2014. Altered pulmonary lymphatic development in infants with chronic lung disease. BioMed. Res. Int. 2014:109891.
47. Meng, Q., J. A. Lima, H. Lai, D. Vlahov, D. D. Celentano, J. B. Margolick, et al. 2003. Elevated C-reactive protein levels are associated with endothelial dysfunction in chronic cocaine users. Int. J. Cardiol. 88:191–198.
48. Mirrakhimov, A. E., A. M. Ali, A. Barbaryan, and S. Prueksaritanond. 2013. Human immunodeficiency virus and pulmonary arterial hypertension. ISRN Cardiol. 903454.
49. Murray, J. F. 2013. Epidemiology of human immunodeficiency virus-associated pulmonary disease. Clin. Chest Med. 34:165–179.
50. Murray, R. J., J. E. Smialek, M. Golle, and R. J. Albin. 1989. Pulmonary artery medial hypertrophy in cocaine users without foreign particle microembolization. Chest 96:1050–1053.
51. Nair, M. P., K. C. Chadha, R. G. Hewitt, S. Mahajan, A. Sweet, and S. A. Schwartz. 2000. Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin. Diagn. Lab. Immunol. 7:96–100.
52. O’Donnell, A. E., F. G. Mappin, T. J. Sebo, and H. Tazelaar. 1991. Interstitial pneumonitis associated with “crack” cocaine abuse. Chest 100:1155–1157.
53. Ortinski, P. I. 2014. Cocaine-induced changes in NMDA receptor signaling. Mol. Neurobiol. 50:494–506.
54. Pare, J. P., G. Cote, and R. S. Fraser. 1989. Long-term followup of drug abusers with intravenous talcosis. Am. Rev. Respir. Dis. 139:233–241.
55. Park, I. W., C. K. Ullrich, E. Schoenberger, R. K. Ganju, and J. E. Groopman. 2001. HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation. J. Immunol. 167:2766–2771.
56. Pradhan, L., D. Mondal, S. Chandra, M. Ali, and K. C. Agrawal. 2008. Molecular analysis of cocaine-induced endothelial dysfunction: role of endothelin-1 and nitric oxide. Cardiovasc. Toxicol. 8:161–171.
57. Rabinovitch, M. 2001. Pathobiology of pulmonary hypertension. Extracellular matrix. Clin. Chest Med. 22:433–449, Viii.
58. Ricci, A., F. Mignini, D. Tomassoni, and F. Amenta. 2006. Dopamine receptor subtypes in the human pulmonary arterial tree. Auton. Autacoid Pharmacol. 26:361–369.
59. Roth, M. D., K. M. Whittaker, R. Choi, D. P. Tashkin, and G. C. Baldwin. 2005. Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model. J. Leukoc. Biol. 78:1198–203.
60. Rubin, L. J., and D. B. Badesch. 2005. Evaluation and management of the patient with pulmonary arterial hypertension. Ann. Intern. Med. 143:282–292.
61. Saez, C. G., P. Olivares, J. Pallavicini, O. Panes, N. Moreno, T. Massardo, et al. 2011. Increased number of circulating endothelial cells and plasma markers of endothelial damage in chronic cocaine users. Thromb. Res. 128:e18–23.
62. Scourfield, A. T., S. R. Doffman, and R. F. Miller. 2014. Chronic obstructive pulmonary disease in patients with HIV: an emerging problem. Br. J. Hosp. Med. (Lond) 75:678–684.
63. Sehgal, P. B. 2013. Non-genomic STAT5-dependent effects at the endoplasmic reticulum and Golgi apparatus and STAT6- GFP in mitochondria. JAKSTAT 2:e24860.
64. Su, T. P., and T. Hayashi. 2003. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr. Med. Chem. 10:2073–2080.
65. Tammela, T., and K. Alitalo. 2010. Lymphangiogenesis: molecular mechanisms and future promise. Cell 140:460–476.
66. Tjotta, E., O. Hungnes, and B. Grinde. 1991. Survival of HIV- 1 activity after disinfection, temperature and pH changes, or drying. J. Med. Virol. 35:223–227.
67. Torre, D., C. Zeroli, R. Martegani, A. Pugliese, C. Basilico, and F. Speranza. 2000. Levels of the bcl-2 protein, fibronectin and alpha(5)beta(1) fibronectin receptor in HIV-1-infected patients with Kaposi’s sarcoma. Microbes Infect. 2:1831–1833.
68. Tseng, W., M. E. Sutter, and T. E. Albertson. 2014. Stimulants and the lung: review of literature. Clin. Rev. Allergy Immunol. 46:82–100.
69. Tuder, R. M., J. C. Marecki, A. Richter, I. Fijalkowska, and S. Flores. 2007. Pathology of pulmonary hypertension. Clin. Chest Med. 28:23–42, 7.
70. Ullrich, C. K., J. E. Groopman, and R. K. Ganju. 2000. HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. Blood 96:1438–1442.
71. Yao, L. C., and D. M. McDonald. 2014. Plasticity of airway lymphatics in development and disease. Adv. Anat. Embryol. Cell Biol. 214:41–54.
72. Yao, H., M. Duan, and S. Buch. 2011a. Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability. Blood 117:2538–2547.
73. Yao, H., M. Duan, G. Hu, and S. Buch. 2011b. Platelet-derived growth factor B chain is a novel target gene of cocainemediated Notch1 signaling: implications for HIV-associated neurological disorders. J. Neurosci. 31:12449–12454.
74. Yao, H., K. Kim, M. Duan, T. Hayashi, M. Guo, S. Morgello, et al. 2011c. Cocaine hijacks sigma1 receptor to initiate induction of activated leukocyte cell adhesion molecule: implication for increased monocyte adhesion and migration in the CNS. J. Neurosci. 31:5942–5955.
75. Yu, J., X. Zhang, P. M. Kuzontkoski, S. Jiang, W. Zhu, D. Y. Li, et al. 2014. Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway. Cell Commun. Signal. 12:25.
76. Zarei, S., M. Frieden, B. Rubi, P. Villemin, B. R. Gauthier, P. Maechler, et al. 2006. Dopamine modulates von Willebrand factor secretion in endothelial cells via D2-D4 receptors. J. Thromb. Haemost. 4:1588–1595.
77. Zhang, L., D. Looney, D. Taub, S. L. Chang, D. Way, M. H. Witte, et al. 1998. Cocaine opens the blood-brain barrier to HIV-1 invasion. J. Neurovirol. 4:619–626.
78. Zhang, X., J. F. Wang, G. Kunos, and J. E. Groopman. 2007. Cannabinoid modulation of Kaposi’s sarcoma-associated herpesvirus infection and transformation. Cancer Res. 67:7230–7237.
79. Zhang, X., J. Yu, P. M. Kuzontkoski, W. Zhu, D. Y. Li, and J. E. Groopman. 2012. Slit2/Robo4 signaling modulates HIV-1 gp120-induced lymphatic hyperpermeability. PLoS Pathog. 8:e1002461.